Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.23.2
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current:    
Cash and cash equivalents $ 5,077 $ 12,449
Restricted cash 64 439
Accounts receivable, net 2,590 2,252
Prepaids, deposits and other receivables 3,207 2,708
Inventories, net 7,470 8,399
Total current assets 18,408 26,247
Investment – Cansativa 5,777 5,679
Property, plant and equipment, net of accumulated depreciation of $7,990 and $7,120 for June 30, 2023 and December 31, 2022, respectively 13,094 13,963
Assets held for sale - Land 1,500 1,500
Intangible assets, net 2,987 3,354
Operating lease right-of-use assets, net 981 1,303
Other non-current assets 84 52
Total Assets 42,831 52,098
Current:    
Accounts payable 2,300 2,299
Accrued expenses and other current liabilities 3,115 4,238
Loans and borrowings, current portion 471 465
Warrant liability 168 113
Operating lease liabilities, current portion 663 1,239
Deferred revenue 845 1,072
Total current liabilities 7,562 9,426
Loans and borrowing — long-term 908 1,065
Operating lease liabilities — long-term 389 1,087
Other long-term liabilities 24 112
Total Liabilities 8,883 11,690
Contingencies and commitments
Shareholders’ equity    
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of June 30, 2023 and December 31, 2022 0 0
Common shares, without par value, unlimited shares authorized: 45,704,459 and 43,636,783 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 0 0
Additional paid-in capital 222,530 221,313
Accumulated deficit (188,582) (180,905)
Total shareholders' equity 33,948 40,408
Total liabilities and shareholders' equity $ 42,831 $ 52,098